Alkem Laboratories reports over 4-fold jump in Q4 consolidated net profit

30 May 2024 Evaluate

Alkem Laboratories has reported results for fourth quarter (Q4) and year ended March 31, 2024.

The company has reported 27.54% rise in its net profit at Rs 324.97 crore for the quarter under review as compared to Rs 254.79 crore for the same quarter in the previous year. Total income of the company increased by 5.81% at Rs 2449.16 crore for Q4FY24 as compared Rs 2314.59 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported over 4-fold jump in its net profit at Rs 304.48 crore for fourth quarter ended March 31, 2024 as compared to Rs 67.68 crore for the same quarter in the previous year. Total income of the company increased by 1.77% at Rs 3023.99 crore for Q4FY24 as compared Rs 2971.27 crore for the corresponding quarter previous year.

For the year ended March 31, 2024, the company has reported 54.01% fall in its net profit at Rs 1747.15 crore as compared to Rs 1134.47 crore for the previous year. Total income of the company increased by 7.86% at Rs 10053.71 crore for year under review as compared to Rs 9320.84 crore for year ended March 31, 2023.

For the year ended March 31, 2024, on the consolidated basis, the company has reported 79.92% rise in its net profit at Rs 1811.46 crore as compared to Rs 1006.81 crore for the previous year. Total income of the company increased by 9.84% at Rs 12978.42 crore for year under review as compared to Rs 11815.34 crore for year ended March 31, 2023.

Alkem Laboratories Share Price

5431.85 -65.55 (-1.19%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.